Efficacy and safety of subcutaneous tabalumab, a monoclonal antibody to B-cell activating factor, in patients with systemic lupus erythematosus: results from ILLUMINATE-2, a 52-week, phase III, multicentre, randomised, double-blind, placebo-controlled study
Merrill, J T, van Vollenhoven, R F, Buyon, J P, Furie, R A, Stohl, W, Morgan-Cox, M, Dickson, C, Anderson, P W, Lee, C, Berclaz, P-Y, Dörner, T
Published in Annals of the rheumatic diseases (01.02.2016)
Published in Annals of the rheumatic diseases (01.02.2016)
Get full text
Journal Article
Belimumab in the treatment of systemic lupus erythematosus: high disease activity predictors of response
van Vollenhoven, Ronald F, Petri, Michelle A, Cervera, Ricard, Roth, David A, Ji, Beulah N, Kleoudis, Christi S, Zhong, Z John, Freimuth, William
Published in Annals of the rheumatic diseases (01.08.2012)
Published in Annals of the rheumatic diseases (01.08.2012)
Get full text
Journal Article
Addition of infliximab compared with addition of sulfasalazine and hydroxychloroquine to methotrexate in patients with early rheumatoid arthritis (Swefot trial): 1-year results of a randomised trial
van Vollenhoven, RF, Dr, Ernestam, S, MD, Geborek, P, MD, Petersson, IF, MD, Cöster, L, MD, Waltbrand, E, MD, Zickert, A, MD, Theander, J, MD, Thörner, Å, MD, Hellström, H, MD, Teleman, A, MD, Dackhammar, C, MD, Akre, F, MD, Forslind, K, MD, Ljung, L, MD, Oding, R, MD, Chatzidionysiou, A, MD, Wörnert, M, RN, Bratt, J, MD
Published in The Lancet (British edition) (2009)
Published in The Lancet (British edition) (2009)
Get full text
Journal Article
Treatment Algorithms in Systemic Lupus Erythematosus
Muangchan, Chayawee, van Vollenhoven, Ronald F., Bernatsky, Sasha R., Smith, C. Douglas, Hudson, Marie, Inanç, Murat, Rothfield, Naomi F., Nash, Peter T., Furie, Richard A., Senécal, Jean‐Luc, Chandran, Vinod, Burgos‐Vargas, Ruben, Ramsey‐Goldman, Rosalind, Pope, Janet E.
Published in Arthritis care & research (2010) (01.09.2015)
Published in Arthritis care & research (2010) (01.09.2015)
Get full text
Journal Article
Safety profile of belimumab: pooled data from placebo-controlled phase 2 and 3 studies in patients with systemic lupus erythematosus
Wallace, DJ, Navarra, S, Petri, MA, Gallacher, A, Thomas, M, Furie, R, Levy, RA, van Vollenhoven, RF, Cooper, S, Zhong, ZJ, Freimuth, W, Cervera, R
Published in Lupus (01.02.2013)
Published in Lupus (01.02.2013)
Get full text
Journal Article
Tocilizumab in early progressive rheumatoid arthritis: FUNCTION, a randomised controlled trial
Burmester, Gerd R, Rigby, William F, van Vollenhoven, Ronald F, Kay, Jonathan, Rubbert-Roth, Andrea, Kelman, Ariella, Dimonaco, Sophie, Mitchell, Nina
Published in Annals of the rheumatic diseases (01.06.2016)
Published in Annals of the rheumatic diseases (01.06.2016)
Get full text
Journal Article
Trial of Anti-BDCA2 Antibody Litifilimab for Cutaneous Lupus Erythematosus
Werth, Victoria P., Furie, Richard A., Romero-Diaz, Juanita, Navarra, Sandra, Kalunian, Kenneth, van Vollenhoven, Ronald F., Nyberg, Filippa, Kaffenberger, Benjamin H., Sheikh, Saira Z., Radunovic, Goran, Huang, Xiaobi, Clark, George, Carroll, Hua, Naik, Himanshu, Gaudreault, Francois, Meyers, Adam, Barbey, Catherine, Musselli, Cristina, Franchimont, Nathalie
Published in The New England journal of medicine (28.07.2022)
Published in The New England journal of medicine (28.07.2022)
Get full text
Journal Article
Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus
Petri, Michelle, Orbai, Ana-Maria, Alarcón, Graciela S., Gordon, Caroline, Merrill, Joan T., Fortin, Paul R., Bruce, Ian N., Isenberg, David, Wallace, Daniel J., Nived, Ola, Sturfelt, Gunnar, Ramsey-Goldman, Rosalind, Bae, Sang-Cheol, Hanly, John G., Sánchez-Guerrero, Jorge, Clarke, Ann, Aranow, Cynthia, Manzi, Susan, Urowitz, Murray, Gladman, Dafna, Kalunian, Kenneth, Costner, Melissa, Werth, Victoria P., Zoma, Asad, Bernatsky, Sasha, Ruiz-Irastorza, Guillermo, Khamashta, Munther A., Jacobsen, Soren, Buyon, Jill P., Maddison, Peter, Dooley, Mary Anne, van Vollenhoven, Ronald F., Ginzler, Ellen, Stoll, Thomas, Peschken, Christine, Jorizzo, Joseph L., Callen, Jeffrey P., Lim, S. Sam, Fessler, Barri J., Inanc, Murat, Kamen, Diane L., Rahman, Anisur, Steinsson, Kristjan, Franks Jr, Andrew G., Sigler, Lisa, Hameed, Suhail, Fang, Hong, Pham, Ngoc, Brey, Robin, Weisman, Michael H., McGwin Jr, Gerald, Magder, Laurence S.
Published in Arthritis & rheumatology (Hoboken, N.J.) (01.08.2012)
Published in Arthritis & rheumatology (Hoboken, N.J.) (01.08.2012)
Get full text
Journal Article
A phase III, randomized, placebo‐controlled study of belimumab, a monoclonal antibody that inhibits B lymphocyte stimulator, in patients with systemic lupus erythematosus
Furie, Richard, Petri, Michelle, Zamani, Omid, Cervera, Ricard, Wallace, Daniel J., Tegzová, Dana, Sanchez‐Guerrero, Jorge, Schwarting, Andreas, Merrill, Joan T., Chatham, W. Winn, Stohl, William, Ginzler, Ellen M., Hough, Douglas R., Zhong, Z. John, Freimuth, William, van Vollenhoven, Ronald F.
Published in Arthritis & rheumatology (Hoboken, N.J.) (01.12.2011)
Published in Arthritis & rheumatology (Hoboken, N.J.) (01.12.2011)
Get full text
Journal Article
Factors associated with damage accrual in patients with systemic lupus erythematosus: results from the Systemic Lupus International Collaborating Clinics (SLICC) Inception Cohort
Bruce, Ian N, O'Keeffe, Aidan G, Farewell, Vern, Hanly, John G, Manzi, Susan, Su, Li, Gladman, Dafna D, Bae, Sang-Cheol, Sanchez-Guerrero, Jorge, Romero-Diaz, Juanita, Gordon, Caroline, Wallace, Daniel J, Clarke, Ann E, Bernatsky, Sasha, Ginzler, Ellen M, Isenberg, David A, Rahman, Anisur, Merrill, Joan T, Alarcón, Graciela S, Fessler, Barri J, Fortin, Paul R, Petri, Michelle, Steinsson, Kristjan, Dooley, Mary Anne, Khamashta, Munther A, Ramsey-Goldman, Rosalind, Zoma, Asad A, Sturfelt, Gunnar K, Nived, Ola, Aranow, Cynthia, Mackay, Meggan, Ramos-Casals, Manuel, van Vollenhoven, Ronald F, Kalunian, Kenneth C, Ruiz-Irastorza, Guillermo, Lim, Sam, Kamen, Diane L, Peschken, Christine A, Inanc, Murat, Urowitz, Murray B
Published in Annals of the rheumatic diseases (01.09.2015)
Published in Annals of the rheumatic diseases (01.09.2015)
Get full text
Journal Article
VX‐509 (Decernotinib), an Oral Selective JAK‐3 Inhibitor, in Combination With Methotrexate in Patients With Rheumatoid Arthritis
Genovese, Mark C., van Vollenhoven, Ronald F., Pacheco‐Tena, César, Zhang, Yanqiong, Kinnman, Nils
Published in Arthritis & rheumatology (Hoboken, N.J.) (01.01.2016)
Published in Arthritis & rheumatology (Hoboken, N.J.) (01.01.2016)
Get full text
Journal Article
A Multicenter, Randomized, Double‐Blind, Placebo‐Controlled Study to Evaluate the Efficacy and Safety of Treatment With Sirukumab (CNTO 136) in Patients With Active Lupus Nephritis
Rovin, Brad H., van Vollenhoven, Ronald F., Aranow, Cynthia, Wagner, Carrie, Gordon, Robert, Zhuang, Yanli, Belkowski, Stanley, Hsu, Benjamin
Published in Arthritis & rheumatology (Hoboken, N.J.) (01.09.2016)
Published in Arthritis & rheumatology (Hoboken, N.J.) (01.09.2016)
Get full text
Journal Article
Full dose, reduced dose or discontinuation of etanercept in rheumatoid arthritis
van Vollenhoven, Ronald F, Østergaard, Mikkel, Leirisalo-Repo, Marjatta, Uhlig, Till, Jansson, Marita, Larsson, Esbjörn, Brock, Fiona, Franck-Larsson, Karin
Published in Annals of the rheumatic diseases (01.01.2016)
Published in Annals of the rheumatic diseases (01.01.2016)
Get full text
Journal Article
Long-term safety of rituximab in rheumatoid arthritis: 9.5-year follow-up of the global clinical trial programme with a focus on adverse events of interest in RA patients
van Vollenhoven, Ronald F, Emery, Paul, Bingham, Clifton O, Keystone, Edward C, Fleischmann, Roy M, Furst, Daniel E, Tyson, Nicola, Collinson, Neil, Lehane, Patricia B
Published in Annals of the rheumatic diseases (01.09.2013)
Published in Annals of the rheumatic diseases (01.09.2013)
Get full text
Journal Article
Tofacitinib or Adalimumab versus Placebo in Rheumatoid Arthritis
van Vollenhoven, Ronald F, Fleischmann, Roy, Cohen, Stanley, Lee, Eun Bong, García Meijide, Juan A, Wagner, Sylke, Forejtova, Sarka, Zwillich, Samuel H, Gruben, David, Koncz, Tamas, Wallenstein, Gene V, Krishnaswami, Sriram, Bradley, John D, Wilkinson, Bethanie
Published in The New England journal of medicine (09.08.2012)
Published in The New England journal of medicine (09.08.2012)
Get full text
Journal Article
Adjustment of therapy in rheumatoid arthritis on the basis of achievement of stable low disease activity with adalimumab plus methotrexate or methotrexate alone: the randomised controlled OPTIMA trial
Smolen, Josef S, Prof, Emery, Paul, Prof, Fleischmann, Roy, Prof, van Vollenhoven, Ronald F, Prof, Pavelka, Karel, Prof, Durez, Patrick, Prof, Guérette, Benoît, PhD, Kupper, Hartmut, MD, Redden, Laura, MD, Arora, Vipin, PhD, Kavanaugh, Arthur, Prof
Published in The Lancet (British edition) (25.01.2014)
Published in The Lancet (British edition) (25.01.2014)
Get full text
Journal Article
Tocilizumab combination therapy or monotherapy or methotrexate monotherapy in methotrexate-naive patients with early rheumatoid arthritis: 2-year clinical and radiographic results from the randomised, placebo-controlled FUNCTION trial
Burmester, Gerd R, Rigby, William F, van Vollenhoven, Ronald F, Kay, Jonathan, Rubbert-Roth, Andrea, Blanco, Ricardo, Kadva, Alysha, Dimonaco, Sophie
Published in Annals of the rheumatic diseases (01.07.2017)
Published in Annals of the rheumatic diseases (01.07.2017)
Get full text
Journal Article
Atacicept in patients with rheumatoid arthritis and an inadequate response to methotrexate: Results of a phase II, randomized, placebo‐controlled trial
van Vollenhoven, R. F., Kinnman, N., Vincent, E., Wax, S., Bathon, J.
Published in Arthritis & rheumatology (Hoboken, N.J.) (01.07.2011)
Published in Arthritis & rheumatology (Hoboken, N.J.) (01.07.2011)
Get full text
Journal Article